New Mission, New Website coming soon! Learn more now.

Equities logo
Search
Close this search box.

Savara Receives $5 Million Award From Cystic Fibrosis Foundation Therapeutics to Advance MRSA Cure

Award will support Phase III study of AeroVanc, the first inhaled treatment for MRSA in cystic fibrosis .